Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!

Harnessing Your Body's Own Chemistry to Treat Ovarian Cancer


This is an older article that may not reflect Dr. Mercola’s current view on this topic. Use our search engine to find Dr. Mercola’s latest position on any health topic.

Researchers have discovered that a low dose of the opioid antagonist naltrexone (LDN) can have an extraordinarily potent antitumor effect on human ovarian cancer in tissue culture.

The discovery provides new insights into the pathogenesis and treatment of ovarian neoplasia, which is the 4th leading cause of cancer-related mortality among U.S. women. The strategy of using LDN therapy to repress cancer was first reported over 30 years ago. Naltrexone causes an elevation in your body's own opioids and opioid receptors.


By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Service.